About this trial
The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana.
These "implementation support strategies (ISS)" are implementation strategies relevant to implementation support, which is concerned with moving (implementation) research into (implementation) practice.
The ultimate goal is to facilitate health system adoption and sustainment.
Eligibility criteria
Qualifiers
ability to give consent per Institutional Review Board stipulations
residing in the Central Region
having no medical characteristics that would interfere with the ability to participate fully
the willingness to participate in this study.
Disqualifiers
Women will be excluded if they are pregnant or have had a hysterectomy.
WLWH who have a cervix are the main target population to develop the HOPE toolkit.
Women who are below 25 and those who are above 65 years will be excluded.
Trial design
Treatments tested in this trial
- Health providers and management at IG sites will receive ISS (i.e., management support, capacity-building, and social network support) and training on the HOPE implementation plan
- Control Group
Treatment groups
Sponsors and collaborators
Baylor University
Lead sponsor
National Cancer Institute (NCI)
Collaborator